Prothena Corporation plc is a global, late-stage clinical biotechnology company seeking to fundamentally change the course of progressive diseases with its clinical pipeline of novel therapeutic antibodies.
Social Media Links
REPORT RATINGS
4.8 / 5.0 (242)
Prothena Corp reports have an aggregate usefulness score of 4.8 based on 242 reviews.